FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2766357535> ?p ?o ?g. }

• W2766357535 endingPage "1196" @default.
• W2766357535 startingPage "1190" @default.
• W2766357535 abstract "To evaluate the safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in patients with hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co-infection in an urban HIV clinic.A retrospective cohort study of 40 subjects co-infected with HIV-1 and HCV treated with the fixed-dose combination of ledipasvir and sofosbuvir for 12 wk from 2014 to 2016. All patients included were receiving antiretroviral therapy (ART) with HIV RNA values of 100 copies/mL or fewer regardless of baseline HCV RNA level. The primary end point was a sustained virologic response of HCV at 12 wk (SVR12) after the end of therapy.Of the 40 patients enrolled, 55% were black, 22.5% had been previously treated for HCV, and 25% had cirrhosis. The patients were on a wide range of ART. Overall, 39 patients (97.5%) had a SVR 12 after the end of therapy, including rates of 97.1% in patients with HCV genotype 1a and 100% in those with HCV genotype 1b. One patient with HCV genotype 3a was included and achieved SVR12. Rates of SVR12 were similar regardless of previous treatment or the presence of compensated cirrhosis. Only 1 patient experienced relapse at week 12 following treatment and deep sequencing didn't reveal any resistance associated mutation in the NS5A or NS5B region. Interestingly, 7 (17.5%) patients who were adherent to ART experienced HIV viral breakthrough which resolved after continuing the same ART regimen. Two (5%) patients experienced HIV-1 virologic rebound due to noncompliance with HIV therapy, which resolved after resuming the same ART regimen. No severe adverse events were observed and no patient discontinued treatment because of adverse events. The most common adverse events included headache (12.5%), fatigue (10%), and diarrhea (2.5%).This retrospective study demonstrated the high rates of SVR12 of ledipasvir/sofosbuvir on HCV eradication in patients co-infected with HCV and HIV, regardless of HCV baseline levels, HCV treatment history or cirrhosis condition. The oral combination of ledipasvir/sofosbuvir represents a safe and well tolerated HCV treatment option that does not require modification for many of the common HIV ART. Occasional HIV virologic rebound occurred but later resolved without the need to change ART." @default.
• W2766357535 created "2017-11-10" @default.
• W2766357535 creator A5006883172 @default.
• W2766357535 creator A5013317051 @default.
• W2766357535 creator A5025248343 @default.
• W2766357535 creator A5043506826 @default.
• W2766357535 creator A5069639790 @default.
• W2766357535 creator A5070636461 @default.
• W2766357535 creator A5078424905 @default.
• W2766357535 date "2017-10-28" @default.
• W2766357535 modified "2023-09-25" @default.
• W2766357535 title "Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients" @default.
• W2766357535 cites W1606880763 @default.
• W2766357535 cites W2030212395 @default.
• W2766357535 cites W2030470608 @default.
• W2766357535 cites W2049390811 @default.
• W2766357535 cites W2072462822 @default.
• W2766357535 cites W2078781922 @default.
• W2766357535 cites W2081897332 @default.
• W2766357535 cites W2085652845 @default.
• W2766357535 cites W2092646281 @default.
• W2766357535 cites W2104103604 @default.
• W2766357535 cites W2118771356 @default.
• W2766357535 cites W2151554611 @default.
• W2766357535 cites W2156006417 @default.
• W2766357535 cites W2322338678 @default.
• W2766357535 cites W2332403844 @default.
• W2766357535 cites W2546422927 @default.
• W2766357535 doi "https://doi.org/10.4254/wjh.v9.i30.1190" @default.
• W2766357535 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5666305" @default.
• W2766357535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29109851" @default.
• W2766357535 hasPublicationYear "2017" @default.
• W2766357535 type Work @default.
• W2766357535 sameAs 2766357535 @default.
• W2766357535 citedByCount "2" @default.
• W2766357535 countsByYear W27663575352021 @default.
• W2766357535 countsByYear W27663575352023 @default.
• W2766357535 crossrefType "journal-article" @default.
• W2766357535 hasAuthorship W2766357535A5006883172 @default.
• W2766357535 hasAuthorship W2766357535A5013317051 @default.
• W2766357535 hasAuthorship W2766357535A5025248343 @default.
• W2766357535 hasAuthorship W2766357535A5043506826 @default.
• W2766357535 hasAuthorship W2766357535A5069639790 @default.
• W2766357535 hasAuthorship W2766357535A5070636461 @default.
• W2766357535 hasAuthorship W2766357535A5078424905 @default.
• W2766357535 hasBestOaLocation W27663575351 @default.
• W2766357535 hasConcept C126322002 @default.
• W2766357535 hasConcept C142462285 @default.
• W2766357535 hasConcept C159047783 @default.
• W2766357535 hasConcept C2522874641 @default.
• W2766357535 hasConcept C2775999097 @default.
• W2766357535 hasConcept C2776408679 @default.
• W2766357535 hasConcept C2776455275 @default.
• W2766357535 hasConcept C2777214474 @default.
• W2766357535 hasConcept C2778390639 @default.
• W2766357535 hasConcept C2780040827 @default.
• W2766357535 hasConcept C2781413609 @default.
• W2766357535 hasConcept C71924100 @default.
• W2766357535 hasConcept C90924648 @default.
• W2766357535 hasConceptScore W2766357535C126322002 @default.
• W2766357535 hasConceptScore W2766357535C142462285 @default.
• W2766357535 hasConceptScore W2766357535C159047783 @default.
• W2766357535 hasConceptScore W2766357535C2522874641 @default.
• W2766357535 hasConceptScore W2766357535C2775999097 @default.
• W2766357535 hasConceptScore W2766357535C2776408679 @default.
• W2766357535 hasConceptScore W2766357535C2776455275 @default.
• W2766357535 hasConceptScore W2766357535C2777214474 @default.
• W2766357535 hasConceptScore W2766357535C2778390639 @default.
• W2766357535 hasConceptScore W2766357535C2780040827 @default.
• W2766357535 hasConceptScore W2766357535C2781413609 @default.
• W2766357535 hasConceptScore W2766357535C71924100 @default.
• W2766357535 hasConceptScore W2766357535C90924648 @default.
• W2766357535 hasIssue "30" @default.
• W2766357535 hasLocation W27663575351 @default.
• W2766357535 hasLocation W27663575352 @default.
• W2766357535 hasLocation W27663575353 @default.
• W2766357535 hasLocation W27663575354 @default.
• W2766357535 hasOpenAccess W2766357535 @default.
• W2766357535 hasPrimaryLocation W27663575351 @default.
• W2766357535 hasRelatedWork W2116998649 @default.
• W2766357535 hasRelatedWork W2287220040 @default.
• W2766357535 hasRelatedWork W2420993274 @default.
• W2766357535 hasRelatedWork W2585250246 @default.
• W2766357535 hasRelatedWork W2606527564 @default.
• W2766357535 hasRelatedWork W2884137513 @default.
• W2766357535 hasRelatedWork W2969696875 @default.
• W2766357535 hasRelatedWork W3024700057 @default.
• W2766357535 hasRelatedWork W4245657394 @default.
• W2766357535 hasRelatedWork W4247984509 @default.
• W2766357535 hasVolume "9" @default.
• W2766357535 isParatext "false" @default.
• W2766357535 isRetracted "false" @default.
• W2766357535 magId "2766357535" @default.
• W2766357535 workType "article" @default.